Studying Biomarkers in Urine Samples From Younger Patients With Wilms Tumor

NCT01614808 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2015-05-07

No results posted yet for this study

Summary

This research study is looking at biomarkers in urine samples from patients with Wilms tumor. Studying samples of urine from patients with cancer in the laboratory may help doctors identify and learn more about biomarkers related to cancer. It may also help doctors predict how patients will respond to treatment

Conditions

  • Recurrent Wilms Tumor and Other Childhood Kidney Tumors
  • Stage III Wilms Tumor

Interventions

OTHER

laboratory biomarker analysis

Correlative studies

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH
  • Children's Oncology Group

    lead NETWORK

Principal Investigators

  • Dawn Maclellan, MD · Children's Oncology Group

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2012-06-30
Completion
2012-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01614808 on ClinicalTrials.gov